What is the current valuation of the Transplantation Market as of 2024?

The Transplantation Market was valued at 16.86 USD Billion in 2024. Read More

What is the projected market valuation for the Transplantation Market in 2035?

The market is projected to reach 45.77 USD Billion by 2035. Read More

What is the expected CAGR for the Transplantation Market during the forecast period 2025 - 2035?

The expected CAGR for the Transplantation Market during 2025 - 2035 is 9.5%. Read More

Which organ type segment is projected to have the highest valuation by 2035?

The Kidney segment is projected to reach 13.0 USD Billion by 2035. Read More

How does the valuation of Living Donor Transplantation compare to Deceased Donor Transplantation by 2035?

By 2035, Living Donor Transplantation is expected to reach 20.1 USD Billion, surpassing Deceased Donor Transplantation at 17.2 USD Billion. Read More

What are the projected valuations for Solid Organ Transplantation and Stem Cell Transplantation by 2035?

Solid Organ Transplantation is projected to reach 22.5 USD Billion, while Stem Cell Transplantation is expected to reach 10.5 USD Billion by 2035. Read More

Which end-use segment is anticipated to have the highest growth by 2035?

The Hospitals segment is anticipated to grow to 17.2 USD Billion by 2035. Read More

Who are the key players in the Transplantation Market?

Key players include United Therapeutics Corporation, Organogenesis Inc., Astellas Pharma Inc., and AbbVie Inc. Read More

What is the projected valuation for the Pancreas organ type segment by 2035?

The Pancreas organ type segment is projected to reach 8.77 USD Billion by 2035. Read More

What is the expected growth trend for Tissue Transplantation by 2035?

Tissue Transplantation is expected to grow to 12.77 USD Billion by 2035. Read More

Transplantation Market

Transplantation Market Research Report: Size, Share, Trend Analysis By Organ Type (Kidney, Liver, Heart, Lung, Pancreas), By Transplantation Type (Deceased Donor Transplantation, Living Donor Transplantation, Xenotransplantation), By Applications (Solid Organ Transplantation, Stem Cell Transplantation, Tissue Transplantation), By End-use (Hospitals, Transplant Centers, Specialty Clinics), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

9.5%

2024 Market Size

$ 16.86 Billion

2035 Market Size

$ 45.77 Billion

Healthcare ● Updated August 2026 Report ID: MRFR/HC/10345-HCR | Pages: 200 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Methodology Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Organ Type (USD Billion) | |
  1. 4.1.1 Kidney | |
  2. 4.1.2 Liver | |
  3. 4.1.3 Heart | |
  4. 4.1.4 Lung | |
  5. 4.1.5 Pancreas |
2. 4.2 Healthcare, BY Transplantation Type (USD Billion) | |
  1. 4.2.1 Deceased Donor Transplantation | |
  2. 4.2.2 Living Donor Transplantation | |
  3. 4.2.3 Xenotransplantation |
3. 4.3 Healthcare, BY Application (USD Billion) | |
  1. 4.3.1 Solid Organ Transplantation | |
  2. 4.3.2 Stem Cell Transplantation | |
  3. 4.3.3 Tissue Transplantation |
4. 4.4 Healthcare, BY End-use (USD Billion) | |
  1. 4.4.1 Hospitals | |
  2. 4.4.2 Transplant Centers | |
  3. 4.4.3 Specialty Clinics |
5. 4.5 Healthcare, BY Region (USD Billion) | |
  1. 4.5.1 North America | | |
    1. 4.5.1.1 US | | |
    2. 4.5.1.2 Canada | |
  2. 4.5.2 Europe | | |
    1. 4.5.2.1 Germany | | |
    2. 4.5.2.2 UK | | |
    3. 4.5.2.3 France | | |
    4. 4.5.2.4 Russia | | |
    5. 4.5.2.5 Italy | | |
    6. 4.5.2.6 Spain | | |
    7. 4.5.2.7 Rest of Europe | |
  3. 4.5.3 APAC | | |
    1. 4.5.3.1 China | | |
    2. 4.5.3.2 India | | |
    3. 4.5.3.3 Japan | | |
    4. 4.5.3.4 South Korea | | |
    5. 4.5.3.5 Malaysia | | |
    6. 4.5.3.6 Thailand | | |
    7. 4.5.3.7 Indonesia | | |
    8. 4.5.3.8 Rest of APAC | |
  4. 4.5.4 South America | | |
    1. 4.5.4.1 Brazil | | |
    2. 4.5.4.2 Mexico | | |
    3. 4.5.4.3 Argentina | | |
    4. 4.5.4.4 Rest of South America | |
  5. 4.5.5 MEA | | |
    1. 4.5.5.1 GCC Countries | | |
    2. 4.5.5.2 South Africa | | |
    3. 4.5.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 United Therapeutics Corporation (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Organogenesis Inc. (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Astellas Pharma Inc. (JP) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 AbbVie Inc. (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Medtronic plc (IE) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Hoffmann-La Roche Ltd (CH) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Sandoz International GmbH (CH) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 NantKwest Inc. (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 TransMedics Inc. (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY ORGAN TYPE |
7. 6.4 US MARKET ANALYSIS BY TRANSPLANTATION TYPE |
8. 6.5 US MARKET ANALYSIS BY APPLICATION |
9. 6.6 US MARKET ANALYSIS BY END-USE |
10. 6.7 CANADA MARKET ANALYSIS BY ORGAN TYPE |
11. 6.8 CANADA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
12. 6.9 CANADA MARKET ANALYSIS BY APPLICATION |
13. 6.10 CANADA MARKET ANALYSIS BY END-USE |
14. 6.11 EUROPE MARKET ANALYSIS |
15. 6.12 GERMANY MARKET ANALYSIS BY ORGAN TYPE |
16. 6.13 GERMANY MARKET ANALYSIS BY TRANSPLANTATION TYPE |
17. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION |
18. 6.15 GERMANY MARKET ANALYSIS BY END-USE |
19. 6.16 UK MARKET ANALYSIS BY ORGAN TYPE |
20. 6.17 UK MARKET ANALYSIS BY TRANSPLANTATION TYPE |
21. 6.18 UK MARKET ANALYSIS BY APPLICATION |
22. 6.19 UK MARKET ANALYSIS BY END-USE |
23. 6.20 FRANCE MARKET ANALYSIS BY ORGAN TYPE |
24. 6.21 FRANCE MARKET ANALYSIS BY TRANSPLANTATION TYPE |
25. 6.22 FRANCE MARKET ANALYSIS BY APPLICATION |
26. 6.23 FRANCE MARKET ANALYSIS BY END-USE |
27. 6.24 RUSSIA MARKET ANALYSIS BY ORGAN TYPE |
28. 6.25 RUSSIA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
29. 6.26 RUSSIA MARKET ANALYSIS BY APPLICATION |
30. 6.27 RUSSIA MARKET ANALYSIS BY END-USE |
31. 6.28 ITALY MARKET ANALYSIS BY ORGAN TYPE |
32. 6.29 ITALY MARKET ANALYSIS BY TRANSPLANTATION TYPE |
33. 6.30 ITALY MARKET ANALYSIS BY APPLICATION |
34. 6.31 ITALY MARKET ANALYSIS BY END-USE |
35. 6.32 SPAIN MARKET ANALYSIS BY ORGAN TYPE |
36. 6.33 SPAIN MARKET ANALYSIS BY TRANSPLANTATION TYPE |
37. 6.34 SPAIN MARKET ANALYSIS BY APPLICATION |
38. 6.35 SPAIN MARKET ANALYSIS BY END-USE |
39. 6.36 REST OF EUROPE MARKET ANALYSIS BY ORGAN TYPE |
40. 6.37 REST OF EUROPE MARKET ANALYSIS BY TRANSPLANTATION TYPE |
41. 6.38 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
42. 6.39 REST OF EUROPE MARKET ANALYSIS BY END-USE |
43. 6.40 APAC MARKET ANALYSIS |
44. 6.41 CHINA MARKET ANALYSIS BY ORGAN TYPE |
45. 6.42 CHINA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
46. 6.43 CHINA MARKET ANALYSIS BY APPLICATION |
47. 6.44 CHINA MARKET ANALYSIS BY END-USE |
48. 6.45 INDIA MARKET ANALYSIS BY ORGAN TYPE |
49. 6.46 INDIA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
50. 6.47 INDIA MARKET ANALYSIS BY APPLICATION |
51. 6.48 INDIA MARKET ANALYSIS BY END-USE |
52. 6.49 JAPAN MARKET ANALYSIS BY ORGAN TYPE |
53. 6.50 JAPAN MARKET ANALYSIS BY TRANSPLANTATION TYPE |
54. 6.51 JAPAN MARKET ANALYSIS BY APPLICATION |
55. 6.52 JAPAN MARKET ANALYSIS BY END-USE |
56. 6.53 SOUTH KOREA MARKET ANALYSIS BY ORGAN TYPE |
57. 6.54 SOUTH KOREA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
58. 6.55 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
59. 6.56 SOUTH KOREA MARKET ANALYSIS BY END-USE |
60. 6.57 MALAYSIA MARKET ANALYSIS BY ORGAN TYPE |
61. 6.58 MALAYSIA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
62. 6.59 MALAYSIA MARKET ANALYSIS BY APPLICATION |
63. 6.60 MALAYSIA MARKET ANALYSIS BY END-USE |
64. 6.61 THAILAND MARKET ANALYSIS BY ORGAN TYPE |
65. 6.62 THAILAND MARKET ANALYSIS BY TRANSPLANTATION TYPE |
66. 6.63 THAILAND MARKET ANALYSIS BY APPLICATION |
67. 6.64 THAILAND MARKET ANALYSIS BY END-USE |
68. 6.65 INDONESIA MARKET ANALYSIS BY ORGAN TYPE |
69. 6.66 INDONESIA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
70. 6.67 INDONESIA MARKET ANALYSIS BY APPLICATION |
71. 6.68 INDONESIA MARKET ANALYSIS BY END-USE |
72. 6.69 REST OF APAC MARKET ANALYSIS BY ORGAN TYPE |
73. 6.70 REST OF APAC MARKET ANALYSIS BY TRANSPLANTATION TYPE |
74. 6.71 REST OF APAC MARKET ANALYSIS BY APPLICATION |
75. 6.72 REST OF APAC MARKET ANALYSIS BY END-USE |
76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
77. 6.74 BRAZIL MARKET ANALYSIS BY ORGAN TYPE |
78. 6.75 BRAZIL MARKET ANALYSIS BY TRANSPLANTATION TYPE |
79. 6.76 BRAZIL MARKET ANALYSIS BY APPLICATION |
80. 6.77 BRAZIL MARKET ANALYSIS BY END-USE |
81. 6.78 MEXICO MARKET ANALYSIS BY ORGAN TYPE |
82. 6.79 MEXICO MARKET ANALYSIS BY TRANSPLANTATION TYPE |
83. 6.80 MEXICO MARKET ANALYSIS BY APPLICATION |
84. 6.81 MEXICO MARKET ANALYSIS BY END-USE |
85. 6.82 ARGENTINA MARKET ANALYSIS BY ORGAN TYPE |
86. 6.83 ARGENTINA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
87. 6.84 ARGENTINA MARKET ANALYSIS BY APPLICATION |
88. 6.85 ARGENTINA MARKET ANALYSIS BY END-USE |
89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY ORGAN TYPE |
90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE |
93. 6.90 MEA MARKET ANALYSIS |
94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY ORGAN TYPE |
95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY TRANSPLANTATION TYPE |
96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END-USE |
98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY ORGAN TYPE |
99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END-USE |
102. 6.99 REST OF MEA MARKET ANALYSIS BY ORGAN TYPE |
103. 6.100 REST OF MEA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
104. 6.101 REST OF MEA MARKET ANALYSIS BY APPLICATION |
105. 6.102 REST OF MEA MARKET ANALYSIS BY END-USE |
106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
107. 6.104 RESEARCH PROCESS OF MRFR |
108. 6.105 DRO ANALYSIS OF HEALTHCARE |
109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
112. 6.109 HEALTHCARE, BY ORGAN TYPE, 2024 (% SHARE) |
113. 6.110 HEALTHCARE, BY ORGAN TYPE, 2024 TO 2035 (USD Billion) |
114. 6.111 HEALTHCARE, BY TRANSPLANTATION TYPE, 2024 (% SHARE) |
115. 6.112 HEALTHCARE, BY TRANSPLANTATION TYPE, 2024 TO 2035 (USD Billion) |
116. 6.113 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
117. 6.114 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
118. 6.115 HEALTHCARE, BY END-USE, 2024 (% SHARE) |
119. 6.116 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Billion) |
120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
121. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY END-USE, 2025-2035 (USD Billion) |
123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY END-USE, 2025-2035 (USD Billion) |
124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY END-USE, 2025-2035 (USD Billion) |
125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY END-USE, 2025-2035 (USD Billion) |
126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY END-USE, 2025-2035 (USD Billion) |
127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY END-USE, 2025-2035 (USD Billion) |
128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY END-USE, 2025-2035 (USD Billion) |
129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY END-USE, 2025-2035 (USD Billion) |
130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY END-USE, 2025-2035 (USD Billion) |
131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY END-USE, 2025-2035 (USD Billion) |
132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY END-USE, 2025-2035 (USD Billion) |
133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY END-USE, 2025-2035 (USD Billion) |
134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY END-USE, 2025-2035 (USD Billion) |
135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY END-USE, 2025-2035 (USD Billion) |
136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY END-USE, 2025-2035 (USD Billion) |
137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY END-USE, 2025-2035 (USD Billion) |
138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY END-USE, 2025-2035 (USD Billion) |
139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY END-USE, 2025-2035 (USD Billion) |
140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY END-USE, 2025-2035 (USD Billion) |
141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY END-USE, 2025-2035 (USD Billion) |
142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY END-USE, 2025-2035 (USD Billion) |
143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY END-USE, 2025-2035 (USD Billion) |
144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY END-USE, 2025-2035 (USD Billion) |
145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY END-USE, 2025-2035 (USD Billion) |
146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY END-USE, 2025-2035 (USD Billion) |
147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY END-USE, 2025-2035 (USD Billion) |
148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY END-USE, 2025-2035 (USD Billion) |
149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY END-USE, 2025-2035 (USD Billion) |
150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY APPLICATION, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY END-USE, 2025-2035 (USD Billion) |
151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
152. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Transplantation Market Segmentation

Transplantation Market By Organ Type (USD Billion, 2025-2035)

Kidney
Liver
Heart
Lung
Pancreas

Transplantation Market By Transplantation Type (USD Billion, 2025-2035)

Deceased Donor Transplantation
Living Donor Transplantation
Xenotransplantation

Transplantation Market By Application (USD Billion, 2025-2035)

Solid Organ Transplantation
Stem Cell Transplantation
Tissue Transplantation

Transplantation Market By End-use (USD Billion, 2025-2035)

Hospitals
Transplant Centers
Specialty Clinics

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”